250 related articles for article (PubMed ID: 34505544)
1. Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia.
Petrykey K; Rezgui AM; Guern ML; Beaulieu P; St-Onge P; Drouin S; Bertout L; Wang F; Baedke JL; Yasui Y; Hudson MM; Raboisson MJ; Laverdière C; Sinnett D; Andelfinger GU; Krajinovic M
Pharmacogenomics; 2021 Sep; 22(14):885-901. PubMed ID: 34505544
[No Abstract] [Full Text] [Related]
2. Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study.
Petrykey K; Lippé S; Robaey P; Sultan S; Laniel J; Drouin S; Bertout L; Beaulieu P; St-Onge P; Boulet-Craig A; Rezgui A; Yasui Y; Sapkota Y; Krull KR; Hudson MM; Laverdière C; Sinnett D; Krajinovic M
PLoS One; 2019; 14(6):e0217314. PubMed ID: 31181069
[TBL] [Abstract][Full Text] [Related]
3. Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivors.
Shalmiev A; Nadeau G; Aaron M; Ouimet-Grennan E; Drouin S; Bertout L; Beaulieu P; St-Onge P; Veilleux LN; Rauch F; Rezgui A; Petrykey K; Laverdière C; Sinnett D; Alos N; Krajinovic M
Pharmacogenomics J; 2022 Feb; 22(1):19-24. PubMed ID: 34446917
[TBL] [Abstract][Full Text] [Related]
4. Identification of genetic association between cardiorespiratory fitness and the trainability genes in childhood acute lymphoblastic leukemia survivors.
Caru M; Petrykey K; Drouin S; Beaulieu P; St-Onge P; Lemay V; Bertout L; Laverdiere C; Andelfinger G; Krajinovic M; Sinnett D; Curnier D
BMC Cancer; 2019 May; 19(1):443. PubMed ID: 31088516
[TBL] [Abstract][Full Text] [Related]
5. Genomic determinants of long-term cardiometabolic complications in childhood acute lymphoblastic leukemia survivors.
England J; Drouin S; Beaulieu P; St-Onge P; Krajinovic M; Laverdière C; Levy E; Marcil V; Sinnett D
BMC Cancer; 2017 Nov; 17(1):751. PubMed ID: 29126409
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia.
Krajinovic M; Elbared J; Drouin S; Bertout L; Rezgui A; Ansari M; Raboisson MJ; Lipshultz SE; Silverman LB; Sallan SE; Neuberg DS; Kutok JL; Laverdière C; Sinnett D; Andelfinger G
Pharmacogenomics J; 2016 Nov; 16(6):530-535. PubMed ID: 26345518
[TBL] [Abstract][Full Text] [Related]
7. Identification of a single-nucleotide polymorphism within
Aaron M; Nadeau G; Ouimet-Grennan E; Drouin S; Bertout L; Beaulieu P; St-Onge P; Shalmiev A; Veilleux LN; Rauch F; Petrykey K; Laverdière C; Sinnett D; Alos N; Krajinovic M
Pharmacogenomics; 2019 Apr; 20(6):409-420. PubMed ID: 30983502
[No Abstract] [Full Text] [Related]
8. Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencing.
Abaji R; Ceppi F; Patel S; Gagné V; Xu CJ; Spinella JF; Colombini A; Parasole R; Buldini B; Basso G; Conter V; Cazzaniga G; Leclerc JM; Laverdière C; Sinnett D; Krajinovic M
Pharmacogenomics; 2018 Oct; 19(15):1181-1193. PubMed ID: 30191766
[TBL] [Abstract][Full Text] [Related]
9. Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients.
Abaji R; Gagné V; Xu CJ; Spinella JF; Ceppi F; Laverdière C; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
Oncotarget; 2017 Jul; 8(27):43752-43767. PubMed ID: 28574850
[TBL] [Abstract][Full Text] [Related]
10. Genetic Factors and Long-term Treatment-Related Neurocognitive Deficits, Anxiety, and Depression in Childhood Leukemia Survivors: An Exome-Wide Association Study.
Petrykey K; Lippé S; Sultan S; Robaey P; Drouin S; Affret-Bertout L; Beaulieu P; St-Onge P; Baedke JL; Yasui Y; Hudson MM; Laverdière C; Sinnett D; Krajinovic M
Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):234-243. PubMed ID: 38051303
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in the body mass index of adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort.
Richard MA; Brown AL; Belmont JW; Scheurer ME; Arroyo VM; Foster KL; Kern KD; Hudson MM; Leisenring WM; Okcu MF; Sapkota Y; Yasui Y; Morton LM; Chanock SJ; Robison LL; Armstrong GT; Bhatia S; Oeffinger KC; Lupo PJ; Kamdar KY
Cancer; 2021 Jan; 127(2):310-318. PubMed ID: 33048379
[TBL] [Abstract][Full Text] [Related]
12. Utility of Global Longitudinal Strain by Echocardiography to Detect Left Ventricular Dysfunction in Long-Term Adult Survivors of Childhood Lymphoma and Acute Lymphoblastic Leukemia.
Christiansen JR; Massey R; Dalen H; Kanellopoulos A; Hamre H; Fosså SD; Ruud E; Kiserud CE; Aakhus S
Am J Cardiol; 2016 Aug; 118(3):446-52. PubMed ID: 27296561
[TBL] [Abstract][Full Text] [Related]
13. The PETALE study: Late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors.
Marcoux S; Drouin S; Laverdière C; Alos N; Andelfinger GU; Bertout L; Curnier D; Friedrich MG; Kritikou EA; Lefebvre G; Levy E; Lippé S; Marcil V; Raboisson MJ; Rauch F; Robaey P; Samoilenko M; Séguin C; Sultan S; Krajinovic M; Sinnett D
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27917589
[TBL] [Abstract][Full Text] [Related]
14. Physical fitness and neurocognitive outcomes in adult survivors of childhood acute lymphoblastic leukemia: A report from the St. Jude Lifetime cohort.
Phillips NS; Howell CR; Lanctot JQ; Partin RE; Pui CH; Hudson MM; Robison LL; Krull KR; Ness KK
Cancer; 2020 Feb; 126(3):640-648. PubMed ID: 31631333
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort.
Nottage KA; Ness KK; Li C; Srivastava D; Robison LL; Hudson MM
Br J Haematol; 2014 May; 165(3):364-74. PubMed ID: 24467690
[TBL] [Abstract][Full Text] [Related]
16. Genetic factors in anthracycline-induced cardiotoxicity in patients treated for pediatric cancer.
Petrykey K; Andelfinger GU; Laverdière C; Sinnett D; Krajinovic M
Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):865-883. PubMed ID: 32772754
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus among adult survivors of childhood acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort Study.
Williams HE; Howell CR; Chemaitilly W; Wilson CL; Karol SE; Nolan VG; Smeltzer MP; Green DM; Ehrhardt MJ; Mulrooney DA; Pui CH; Hudson MM; Robison LL; Ness KK
Cancer; 2020 Feb; 126(4):870-878. PubMed ID: 31714590
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
[TBL] [Abstract][Full Text] [Related]
19. Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia.
Nysom K; Holm K; Lipsitz SR; Mone SM; Colan SD; Orav EJ; Sallan SE; Olsen JH; Hertz H; Jacobsen JR; Lipshultz SE
J Clin Oncol; 1998 Feb; 16(2):545-50. PubMed ID: 9469339
[TBL] [Abstract][Full Text] [Related]
20. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study.
Mulrooney DA; Hyun G; Ness KK; Bhakta N; Pui CH; Ehrhardt MJ; Krull KR; Crom DB; Chemaitilly W; Srivastava DK; Relling MV; Jeha S; Green DM; Yasui Y; Robison LL; Hudson MM
Lancet Haematol; 2019 Jun; 6(6):e306-e316. PubMed ID: 31078468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
